← FDATracker
HomeAdverse Events

CLOZARIL Adverse Event: Breast cancer metastatic

CLOZARIL Adverse Event: Breast cancer metastatic is one of 4,500 adverse events in the FDATracker dataset. Key details — Primary drug: CLOZARIL; Product category: Drug; Primary reaction: Breast cancer metastatic.

Primary drugCLOZARIL
Product categoryDrug
Primary reactionBreast cancer metastatic
All reactionsBreast cancer metastatic; White blood cell count increased
SeriousnessSerious
Patient outcomeUnknown
Patient sexFemale
All drugs reportedCLOZARIL
Reporter countryUS
Reporter type1
Report date20140312
Report ID10005284

🔍 Search all adverse events →